Why I Doubled Down On Credo: Backing the 'Plumbing' of AI Data Centers at $170

Hook & thesis

I doubled down on Credo Technology (CRDO) today at $170.13 after a week of heavy selling that I view as an overreaction to near-term margin noise. The company just reported blistering revenue growth — $479 million in Q1 FY2027, up 114.7% year-over-year — and set an explicit revenue path in optics that management says will exceed $600 million in FY2027. That kind of top-line acceleration matters for companies supplying high-speed connectivity into AI data centers; demand is structural, not cyclical.

Yes, the stock is expensive and volatile. But the market punished Credo for a one-quarter gross margin decline (reported GAAP gross margins fell to 64.5% from 68%) and stock-based compensation that inflates GAAP cost. I view those as manageable execution items against a vastly larger opportunity: Credo is an early beneficiary of higher-speed SerDes, active electrical cables and near-package optics that are required as data centers scale for large AI clusters. That trade-off — temporary margin pressure versus a multi-hundred-million dollar revenue ramp in optics — is why I added to my position.

What the company does and why the market should care

Credo Technology designs and sells connectivity solutions for data infrastructure: integrated circuits, active electrical cables, and SerDes chiplets. These are the physical ‘plumbing’ pieces that let GPUs and other accelerators communicate at very high bandwidth over short distances inside racks and across data halls. As customers push to higher speeds and more disaggregated architectures, demand for Credo’s higher-speed electrical/optical solutions ramps sharply.

Concrete proof: management reported $479 million in Q1 FY2027 revenue (a 114.7% YoY increase) and expects optical revenue to top $600 million in FY2027, with three product lines each contributing more than $100 million. The company’s trailing annual revenue run-rate is now roughly $1.3 billion after the FY2026 outturn — that’s a rapid scale-up from the prior year and is the reason investors are focused on Credo despite a high headline valuation.

Key numbers to anchor the thesis

Valuation framing

At a market cap of roughly $32.0 billion and trailing revenue of about $1.3 billion, Credo trades at roughly 24.6x trailing sales by simple math (market cap / trailing revenue). On an earnings basis, the stock looks expensive at roughly 59x reported P/E, which explains why the market is hypersensitive to margin swings and dilution. That said, if management hits its near-term optics target (>$600 million in FY2027) and the company sustains high gross margins on higher ASP optical products, forward revenue and profit multiple compression could justify a materially higher share price — the market is pricing in growth but demanding flawless execution.

Put differently: the valuation already assumes large market share and commoditized pricing under control. The question is whether Credo can keep expanding margins as revenue scales and avoid concentration-led order volatility. For me, the combination of accelerating top-line, product-led optical growth, and continued customer orders is worth paying up for — if I manage risk tightly.

Technical context and sentiment

Short-term technicals show the stock has been reset: yesterday’s price action left CRDO around $170.13 (previous close $164.17), with the 10-50 day moving averages well above the current price and RSI near 34, signaling that much of the short-term momentum has rolled over. Short-volume was meaningful on 09/03/2026 — on that day roughly 2.83M shares of a ~5.9M total volume were sold short — so there is active short interest creating volatility and amplification on downside moves. That volatility is exactly why we size positions and set a clear stop.

Catalysts that can re-rate the stock

• Execution against the optical revenue target: management’s plan to exceed $600M in optical revenue for FY2027 is the clearest re-rating catalyst.
• Gross margin stabilization or recovery: moving GAAP gross margins back toward or above the mid-60s would remove a key near-term overhang.
• Broader customer diversification or public disclosure of larger purchase orders beyond the top three customers (which today account for roughly 74% of revenue).
• Positive follow-through in quarterly guidance (Q2 guidance that beats consensus) and reduction in stock-based comp as a percent of revenue.

Trade plan - actionable and specific

My posture is aggressive-long with disciplined risk control. I executed an add at $170.13 and set parameters I’m comfortable trading around:

• Entry: $170.13 (filled today)
• Stop-loss: $140.00
• Primary target: $260.00 (primary objective over a long-term horizon)
• Position sizing: allocate only what you can afford to lose given CRDO’s beta and short-interest-driven volatility

Horizon: I view this as a long-term trade: 180 trading days. That length accounts for the time it should take for optical revenue momentum to be reflected in reported quarterly results, for margins to stabilize, and for investors to reprice the shares toward a higher revenue multiple if execution is confirmed. If you prefer shorter time frames, a mid-term target (45 trading days) around $220 could be reasonable if the company posts outperformance in the next report; short-term traders (10 trading days) should expect heightened chop and plan accordingly.

Risks and counterarguments

• Customer concentration: Three customers account for roughly 74% of revenue. A single large customer order pause or re-prioritization could materially dent growth.
• Margin pressure and stock-based comp: GAAP gross margins dipped from 68% to 64.5% recently, and elevated stock-based comp has raised concerns about diluted ‘true’ earnings.
• Valuation vulnerability: The stock trades at a high multiple (roughly 59x P/E and ~24.6x trailing sales under current run-rate math). Any sign of slowing growth would likely trigger outsized downside.
• High volatility / short interest: Recent short-volume and a high beta create the risk of fast, large moves against longs; intraday liquidity can evaporate in sell-offs.
• Execution risk on optical ramp: Hitting >$600M in optical revenue requires supply-chain, manufacturing and customer qualification execution. Misses or slower-than-expected ramp would be punished.

Counterargument: The most compelling counterargument is valuation-implied perfection. Critics say you are paying for a near-perfect rollout and that one misstep — margin pressure, a lost design win, or a large customer pause — will send the stock much lower. That is a valid point. Investors who cannot stomach multi-day 20-40% drawdowns should either size down or stay out. I accept this trade-off because I believe the optical ramp and secular demand for higher-speed connectivity are real and underpriced by market participants who are focused on a single quarter of margin weakness.

What would change my mind

I would reduce the position materially if any of the following occur: (1) guidance is lowered or the optical >$600M target is pulled back; (2) GAAP gross margins continue to deteriorate for two consecutive quarters; (3) we see a sudden, material loss of business from one of the top three customers; or (4) stock-based compensation meaningfully accelerates and is unlikely to normalize as a percent of revenue. Conversely, consistent beats on revenue and margin recovery would prompt a staged add above the initial target.

Conclusion

Doubling down on Credo here is not a complacent buy-the-dip move. It’s a directional wager that connects a multi-hundred-million-dollar optical ramp and structural data-center demand to a company that already scaled from hundreds of millions to roughly $1.3 billion in revenue within a year. The reward-to-risk looks attractive if management nails the optics execution and margins stabilize; the trade will be nimble and sized with respect to the company’s elevated volatility. Entry $170.13, stop $140.00, primary target $260.00 over 180 trading days — that’s how I’m playing it.